3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
5
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
34
Uterine Cervical Neoplasms
24
Fallopian Tube Neoplasms
18
Endometrial Neoplasms
16
Neoplasm Metastasis
10
Lung Neoplasms
9
Pancreatic Neoplasms
8
Stomach Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Transitional Cell
7
Breast Neoplasms
7
Melanoma
6
Carcinoma, Renal Cell
6
Prostatic Neoplasms
5
Esophageal Neoplasms
5
Carcinosarcoma
5
Carcinoma, Hepatocellular
5
Vaginal Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Testicular Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Multiple Myeloma
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Vulvar Neoplasms
2
Interventions
Doxorubicin
6
Ifosfamide
4
Filgrastim
3
belinostat
2
Radiotherapy
2
Imatinib Mesylate
2
sodium thiosulfate
1
saracatinib
1
perifosine
1
brostallicin
1
X-Rays
1
Vincristine
1
Trabectedin
1
Therapeutics
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Injections
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fulvestrant
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
Magnetic Resonance Spectroscopy
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled